Tcg Crossover Management, LLC An2 Therapeutics, Inc. Transaction History
Tcg Crossover Management, LLC
- $950 Million
- Q1 2024
A detailed history of Tcg Crossover Management, LLC transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 1,555,118 shares of ANTX stock, worth $3.22 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
1,555,118
Previous 2,678,209
41.93%
Holding current value
$3.22 Million
Previous $54.9 Million
90.79%
% of portfolio
0.53%
Previous 7.59%
Shares
3 transactions
Others Institutions Holding ANTX
# of Institutions
55Shares Held
13.2MCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.56MShares$3.22 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.39MShares$2.88 Million0.24% of portfolio
-
Bvf Inc San Francisco, CA1.24MShares$2.57 Million0.12% of portfolio
-
Janus Henderson Group PLC London, X01.22MShares$2.53 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.15MShares$2.38 Million0.14% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $40.2M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...